Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Shift Workers Face Higher Miscarriage Risk, Subfertility

July 9 (Bloomberg) -- Women who work irregular shifts suffer more disrupted menstrual cycles, miscarriages and reduced fertility, according to an analysis of data from previous studies presented at a scientific meeting in London.

Irregular hours are associated with a 33 percent greater rate of menstrual disruption and an 80 percent higher rate of subfertility than working regular hours, according to the report to the European Society of Human Reproduction and Embryology today. Those who only worked nights didn’t face an increased risk of menstrual disruption or difficulty conceiving, though they did have more miscarriages.

“If our results are confirmed by other studies, there may be implications for shift workers and their reproduction plans,” one of the study authors, Linden Stocker, a clinical research fellow and obstetrics and gynecology registrar at the University of Southampton, said in a statement.

The findings are based on pooled data from all studies published on the subject from 1969 until January 2013. The studies collectively looked at a total of 119,345 women.

The analysis showed an association between shift work and negative outcomes such as miscarriages; it doesn’t prove that shift work causes the negative outcomes, Stocker said. Disruption of the circadian rhythms that affect the biological function of “clock genes” may explain the link between shift work and reproductive outcomes, she said.

The results should be interpreted cautiously, said Stuart Lavery, a consultant gynecologist at Hammersmith and Queen Charlotte’s Hospitals and director of IVF Hammersmith in London.

“We can’t make any terribly firm conclusions from this study,” Lavery said at a press conference in London. “In attendance are several confounding factors.”

To contact the reporter on this story: Andrea Gerlin in London at agerlin@bloomberg.net

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.